Pisa syndrome in a cohort of Alzheimer's disease patients

• Published in: Acta neurologica Scandinavica Vol. 111; no. 3; pp. 199 - 201
• Main Authors: Vanacore, N., Suzzareddu, G., Maggini, M., Casula, A., Capelli, P., Raschetti, R.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Munksgaard International Publishers 01-03-2005; Blackwell
• Subjects: Aged; Aged, 80 and over; Alzheimer Disease - complications; Alzheimer Disease - drug therapy; Alzheimer Disease - epidemiology; Alzheimer's disease; Biological and medical sciences; cholinesterase inhibitors; Cholinesterase Inhibitors - adverse effects; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases; Dystonia - chemically induced; Dystonia - epidemiology; Dystonia - etiology; Female; Humans; Incidence; Malformations of the nervous system; Medical sciences; Neurology; Pisa syndrome; Syndrome; Human; Nervous system diseases; Degenerative disease; Alzheimer disease; Central nervous system disease; Cerebral disorder
• ISSN: 0001-6314; 1600-0404
• DOI: 10.1111/j.1600-0404.2005.00388.x

Three Alzheimer's disease patients with Pisa syndrome were presented. These patients were treated with cholinesterase inhibitors within a post‐marketing surveillance study.
The clinical and pharmacological histories of these patients suggest a relation between cholinesterase inhibitors and the pleurothotonus.
The diffuse use of cholinesterase inhibitors in the treatment of dementia may cause an increasing number of Pisa syndrome cases.